Your browser doesn't support javascript.
loading
Treatment of Ulcerative Colitis with Steroids (in Whom, How Long, What Dose, What Form).
George, Lauren A; Cross, Raymond K.
Affiliation
  • George LA; Division of Gastroenterology and Hepatology, University of Maryland School of Medicine, 685 West Baltimore Street, Suite 8-00, Baltimore, MD 21201, USA.
  • Cross RK; Division of Gastroenterology and Hepatology, University of Maryland School of Medicine, 685 West Baltimore Street, Suite 8-00, Baltimore, MD 21201, USA. Electronic address: rcross@som.umaryland.edu.
Gastroenterol Clin North Am ; 49(4): 705-716, 2020 12.
Article de En | MEDLINE | ID: mdl-33121690
ABSTRACT
Corticosteroids are a nonspecific immune modulator used in the treatment of ulcerative colitis. Topical and systemic forms of corticosteroids have been shown to be effective in induction of clinical remission and remain first-line therapy for acute severe ulcerative colitis. A large proportion of patients experience adverse effects, however, including some serious adverse effects, including infection and increased mortality. Newer formulations of gut selective corticosteroids have reduced adverse effects associated with steroids.
Sujet(s)
Mots clés

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Rectocolite hémorragique / Glucocorticoïdes Type d'étude: Etiology_studies Limites: Humans Langue: En Journal: Gastroenterol Clin North Am Sujet du journal: GASTROENTEROLOGIA Année: 2020 Type de document: Article Pays d'affiliation: États-Unis d'Amérique

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Rectocolite hémorragique / Glucocorticoïdes Type d'étude: Etiology_studies Limites: Humans Langue: En Journal: Gastroenterol Clin North Am Sujet du journal: GASTROENTEROLOGIA Année: 2020 Type de document: Article Pays d'affiliation: États-Unis d'Amérique